ARTICLE | Company News
Epimmune, Genencor in therapeutic vaccine deal
July 10, 2001 7:00 AM UTC
EPMN and GCOR entered a 30-month collaboration to develop therapeutic vaccines against hepatitis B virus (HBV), hepatitis C virus (HCV) and human papillomavirus (HPV). GCOR received a 10% stake in EPM...